Related Experiment Videos
In vivo evaluation of modified mandrel-grown vascular prostheses
J A Werkmeister1, G A Edwards, J F White
1CSIRO, Division of Molecular Science, 343 Royal Parade, Parkville, Victoria 3052, Australia. jerome.werkmeister@molsci.csiro.au
Journal of Biomedical Materials Research
|September 17, 1999
Summary
Modified Omniflow Vascular Prostheses (OVPs) with collagen or heparin coatings showed excellent patency and tissue integration in canine models. These vascular grafts demonstrate promising results for future coronary artery applications.
Area of Science:
- Biomaterials Science
- Vascular Surgery
- Regenerative Medicine
Background:
- The Omniflow Vascular Prosthesis (OVP) exhibits superior properties compared to synthetic and biological grafts, especially in low-flow conditions.
- Development of smaller diameter coronary prostheses requires optimization of the inner luminal surface.
- Previous modifications created a uniformly thicker, non-undulating inner surface.
Purpose of the Study:
- To evaluate the efficacy of collagen or heparin surface treatments on modified OVPs.
- To assess patency, tissue integration, wound healing, and endothelialization in a canine model.
- To compare modified OVPs with previously studied unmodified versions.
Main Methods:
- Modified OVPs, with inner surfaces treated with either collagen or heparin, were implanted in a canine model.
- Evaluation included assessment of patency, tissue integration, wound healing, and endothelialization.
- Histological analysis was performed at various explant time points.
Main Results:
- All modified OVPs remained fully patent without thrombus or aneurysms.
- Rapid tissue response observed, with excellent host collagen deposition and minimal inflammatory cells.
- Endothelialization was present early in the central regions, though the intimal layer appeared atypical.
Conclusions:
- Collagen or heparin treatment of modified OVPs did not cause deleterious effects.
- The modified OVPs demonstrated excellent biocompatibility, tissue integration, and patency.
- These findings support the potential of modified OVPs for coronary artery applications.